109 filings
Page 3 of 6
8-K
b6p4n4z72
13 Sep 21
Regulation FD Disclosure
6:05am
8-K
a8fcu
10 Aug 21
Matinas BioPharma Reports Second Quarter 2021 Financial Results and Operational Highlights
6:35am
8-K
l99sln0prw 9i
10 May 21
Matinas BioPharma Reports First Quarter 2021 Financial Results and Operational Highlights
6:35am
8-K
ck8t70zheq2br8ghe
29 Mar 21
Matinas BioPharma Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
6:35am
8-K
8k9k5h h41msbe1gn93l
1 Feb 21
Regulation FD Disclosure
6:03am
8-K
kn2bd0kh
27 Jan 21
Submission of Matters to a Vote of Security Holders
5:28pm
8-K
7vfcg
14 Jan 21
Regulation FD Disclosure
7:00am
8-K
nod52t 4qvm
28 Dec 20
Other Events
6:07am
8-K
bwqbbe3vvo xc
8 Dec 20
Regulation FD Disclosure
12:00am
8-K
fvr9v9 0juwx0zf8r
1 Dec 20
Matinas BioPharma Appoints Hui Liu, Ph.D., M.B.A. as Chief Technology Officer
5:05pm
8-K
y769uwnyk4 ojgqhn5b
25 Nov 20
Entry into a Material Definitive Agreement
4:00pm
8-K
pmdonoi2dl4b66jj
6 Nov 20
Matinas BioPharma Reports Third Quarter 2020 Financial Results and Operational Highlights
7:55am
8-K
88j4 bidquw
4 Nov 20
Submission of Matters to a Vote of Security Holders
4:14pm
8-K
4vc0ufc1x 66
19 Oct 20
Regulation FD Disclosure
6:35am
8-K
2a8gkq8lqat 49nek3zw
15 Sep 20
Matinas BioPharma Appoints Industry Veteran Natasha Giordano to Board of Directors
4:45pm
8-K
nkr769oi7w8pkroe4f
10 Aug 20
Matinas BioPharma Reports Second Quarter 2020 Financial Results and Operational Highlights
4:05pm
8-K
j7vsj
2 Jul 20
Entry into a Material Definitive Agreement
5:09pm
8-K
7nee44avfqmhbwlpbbz4
2 Jun 20
Regulation FD Disclosure
8:00am
8-K
waq7acl rk96kzle
11 May 20
Matinas BioPharma Reports First Quarter 2020 Financial Results and Operational Highlights
5:18pm
8-K
akeu7p dw9qyn
9 Mar 20
Matinas BioPharma Reports Fourth Quarter and Full Year 2019
4:28pm